Eosinophilic Angiitis Presenting with a True, Fusiform, Temporal Artery Aneurysm

Overview

Journal Clin Case Rep

Date 2017 Jun 8

PMID 28588807

Citations 1

Authors

Megan MacDiarmid

Dmitri Nepogodiev

Alok Tiwari

Martin Duddy

Martyn Carey

Paresh Jobanputra

Affiliations

Soon will be listed here.

Abstract

Temporal artery aneurysm is a rare cause of temporal artery swelling in the absence of preceding trauma. Vasculitis other than giant cell arteritis, such as eosinophilic granulomatosis with polyangiitis, should be considered in such cases and a careful assessment of other medium-sized arteries undertaken.

Citing Articles

Development of Eosinophilic Temporal Arteritis and Digital Ischemia in a Patient with Hypereosinophilic Syndrome.

Ishii K, Mizuuchi T, Yamamoto Y, Mori H, Tago M, Kato E Intern Med. 2020; 59(10):1323-1330.

PMID: 32101832 PMC: 7303445. DOI: 10.2169/internalmedicine.3707-19.

References

Pagnoux C, Quemeneur T, Ninet J, Diot E, Kyndt X, de Wazieres B . Treatment of systemic necrotizing vasculitides in patients aged sixty-five years or older: results of a multicenter, open-label, randomized controlled trial of corticosteroid and cyclophosphamide-based induction therapy. Arthritis Rheumatol. 2015; 67(4):1117-27. DOI: 10.1002/art.39011. View

Endo T, Katsuta Y, Kimura Y, Kikuchi A, Aramaki T, Takano T . A variant form of Churg-Strauss syndrome: initial temporal non-giant cell arteritis followed by asthma--is this a distinct clinicopathologic entity?. Hum Pathol. 2000; 31(9):1169-71. DOI: 10.1053/hupa.2000.17992. View

Groh M, Pagnoux C, Baldini C, Bel E, Bottero P, Cottin V . Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (EGPA) Consensus Task Force recommendations for evaluation and management. Eur J Intern Med. 2015; 26(7):545-53. DOI: 10.1016/j.ejim.2015.04.022. View

Peick A, Nichols W, Curtis J, Silver D . Aneurysms and pseudoaneurysms of the superficial temporal artery caused by trauma. J Vasc Surg. 1988; 8(5):606-10. DOI: 10.1067/mva.1988.avs0080606. View

Monach P, Arnold L, Merkel P . Incidence and prevention of bladder toxicity from cyclophosphamide in the treatment of rheumatic diseases: a data-driven review. Arthritis Rheum. 2009; 62(1):9-21. DOI: 10.1002/art.25061. View

Houssiau F, Vasconcelos C, DCruz D, Sebastiani G, de Ramon Garrido E, Danieli M . The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide. Ann Rheum Dis. 2009; 69(1):61-4. DOI: 10.1136/ard.2008.102533. View

Harper L, Morgan M, Walsh M, Hoglund P, Westman K, Flossmann O . Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-up. Ann Rheum Dis. 2011; 71(6):955-60. DOI: 10.1136/annrheumdis-2011-200477. View

Ribi C, Cohen P, Pagnoux C, Mahr A, Arene J, Lauque D . Treatment of Churg-Strauss syndrome without poor-prognosis factors: a multicenter, prospective, randomized, open-label study of seventy-two patients. Arthritis Rheum. 2008; 58(2):586-94. DOI: 10.1002/art.23198. View

Jennette J, Falk R, Bacon P, Basu N, Cid M, Ferrario F . 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 2012; 65(1):1-11. DOI: 10.1002/art.37715. View

10.

Vaglio A, Casazza I, Grasselli C, Corradi D, Sinico R, Buzio C . Churg-Strauss syndrome. Kidney Int. 2009; 76(9):1006-11. DOI: 10.1038/ki.2009.210. View

11.

Lie J, Gordon L, TITUS J . Juvenile temporal arteritis. Biopsy study of four cases. JAMA. 1975; 234(5):496-9. DOI: 10.1001/jama.234.5.496. View

12.

Stone J, Merkel P, Spiera R, Seo P, Langford C, Hoffman G . Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med. 2010; 363(3):221-32. PMC: 3137658. DOI: 10.1056/NEJMoa0909905. View

13.

Woodhouse N, Gok G, Saha S, Howlett D . A rare cause of a parotid mass: spontaneous pseudoaneurysm of the superficial temporal artery. Int J Oral Maxillofac Surg. 2010; 39(12):1234-6. DOI: 10.1016/j.ijom.2010.06.010. View

14.

Comarmond C, Pagnoux C, Khellaf M, Cordier J, Hamidou M, Viallard J . Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): clinical characteristics and long-term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort. Arthritis Rheum. 2012; 65(1):270-81. DOI: 10.1002/art.37721. View

15.

van Uden D, Truijers M, Schipper E, Zeebregts C, Reijnen M . Superficial temporal artery aneurysm: Diagnosis and treatment options. Head Neck. 2012; 35(4):608-14. DOI: 10.1002/hed.21963. View

16.

Ntatsaki E, Carruthers D, Chakravarty K, DCruz D, Harper L, Jayne D . BSR and BHPR guideline for the management of adults with ANCA-associated vasculitis. Rheumatology (Oxford). 2014; 53(12):2306-9. DOI: 10.1093/rheumatology/ket445. View

17.

Scott D, Watts R . Epidemiology and clinical features of systemic vasculitis. Clin Exp Nephrol. 2013; 17(5):607-610. DOI: 10.1007/s10157-013-0830-8. View

18.

Guillevin L, Lhote F, Gayraud M, Cohen P, Jarrousse B, Lortholary O . Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients. Medicine (Baltimore). 1996; 75(1):17-28. DOI: 10.1097/00005792-199601000-00003. View

19.

MASI A, Hunder G, Lie J, Michel B, Bloch D, Arend W . The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum. 1990; 33(8):1094-100. DOI: 10.1002/art.1780330806. View

20.

Mahr A, Guillevin L, Poissonnet M, Ayme S . Prevalences of polyarteritis nodosa, microscopic polyangiitis, Wegener's granulomatosis, and Churg-Strauss syndrome in a French urban multiethnic population in 2000: a capture-recapture estimate. Arthritis Rheum. 2004; 51(1):92-9. DOI: 10.1002/art.20077. View